• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    "Patient-reported outcomes in futibatinib-treated intrahepatic cholangiocarcinoma patients with fgfr2 fusions/rearrangements: results from the foenix-CCA2 study "

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Bridgewater, JA
    Hollebecque, A.
    Furuse, J
    Goyal, L
    Meric-Bernstam, F
    Epstein, R. S.
    Morlock, R.
    Salimi, T.
    Wacheck, V.
    Liu, M
    Benhadji, K.
    Valle, Juan W
    Show allShow less
    Affiliation
    UCL Cancer Institute, London, UK
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    We report patient-reported outcomes (PROs) results from the pivotal phase 2 trial FOENIX-CCA2 (NCT02052778). FOENIX-CCA2 evaluated futibatinib, an irreversible FGFR1–4 inhibitor, among intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions/rearrangements. Futibatinib demonstrated a confirmed objective response rate of 41.7%; adverse events were manageable. PROs were a prespecified secondary objective of the study.
    Citation
    Bridgewater, J A, Hollebecque, A, Furuse, J, Goyal, L, Meric-Bernstam, F, Epstein, R S, Morlock, R, Salimi, T, Wacheck, V, Liu, M, Benhadji, K, Valle, Juan W. "Patient-reported outcomes in futibatinib-treated intrahepatic cholangiocarcinoma patients with fgfr2 fusions/rearrangements: results from the foenix-CCA2 study. Value in Health . 2022
    Journal
    Value in Health
    URI
    http://hdl.handle.net/10541/625198
    DOI
    10.1016/j.jval.2021.11.1065
    Additional Links
    https://dx.doi.org/10.1016/j.jval.2021.11.1065
    Type
    Meetings and Proceedings
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.jval.2021.11.1065
    Scopus Count
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.